Azitra (AZTR) EBITDA Margin Growth (1y) (2023 - 2024)
Azitra (AZTR) EBITDA Margin Growth (1y) (2023 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn | 1,552.00 |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn | 1,536.00 |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn | -170.00 |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn | 1,049.00 |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn | 1,997.00 |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - | - |
| 10 | Azitra | 2.05 Mn | 2.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -3.46 Mn |
| Dec 31, 2023 | 610,123.00 |
| Sep 30, 2023 | 424,584.00 |
| Jun 30, 2023 | 162,693.00 |